Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
David Maloney, MD, PhD, Fred Hutchinson Cancer Research Center, Seattle, WA, discusses the CAR T-cell therapy data he is expecting to be presented at ASH 2019 at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands. Prof. Maloney specifically mentions upcoming data on lisocabtagene maraleucel.
We use necessary cookies to make this site work. Analytics, preference, and marketing cookies are used only if you choose to allow them. You can change your choice at any time. For more information view our Cookie Policy.